ArticleFrontiers in endocrinology2026
Surveillance intensity influences the observed incidence of delayed hyponatremia after microscopic transsphenoidal pituitary surgery: early sodium and sex as risk stratifiers.
Article in Frontiers in endocrinology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Delayed postoperative hyponatremia after transsphenoidal pituitary surgery has a reported incidence of 5-30%, yet how much of this variability reflects biology rather than differences in postoperative sodium surveillance has not been quantified within a single cohort. We retrospectively studied 285 consecutive adults who underwent microscopic transsphenoidal surgery for pituitary adenoma by a single team between 2004 and 2025. Delayed hyponatremia was defined from raw laboratory data as any serum sodium below 135 mmol/L on postoperative days 3-10. Two predefined populations were analyzed: the primary cohort (n = 281) and a surveillance-complete subgroup with at least one measurement on days 5-7 (n = 107). Apparent incidence rose from 16.4% in the primary cohort to 35.5% in the surveillance-complete subgroup and 57.5% with a day-7 measurement; those tested on days 5-7 had 11.4-fold higher odds of recorded delayed hyponatremia than those without late testing (p < 0.001). An apparent two-decade increase largely disappeared once surveillance was held constant: under the assumptions of a direct-standardization analysis, approximately 83% of the observed temporal increase was explained by differences in surveillance intensity. Early postoperative hyponatremia (any sodium below 135 mmol/L on days 0-2) showed the largest univariable association among bedside-available variables: 46.9% of affected patients later developed delayed hyponatremia versus 12.4% without it (relative risk 3.77; odds ratio 6.14), although this did not reach significance after multivariable adjustment within the surveillance-complete subgroup (odds ratio 2.83; 95% CI 0.86-9.33). Female sex was independently associated with the outcome (adjusted odds ratio 2.73), and a significant age-by-sex interaction (p = 0.010) showed consistently elevated risk in women of all ages and risk rising with age in men; age was analyzed continuously. A secondary, exploratory risk-stratification model reached an optimism-corrected area under the curve of 0.645, adequate for hypothesis generation but not clinical deployment. Even within a single surgical team, apparent incidence varied more than threefold with surveillance intensity, suggesting that much of the reported heterogeneity may reflect differences in how the outcome is ascertained rather than between patients. Whether early sodium, sex, and age can direct day 5-7 surveillance instead of screening every patient requires prospective evaluation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.